DJIA 18,034.93 0.00 0.00%
NASDAQ 4,994.60 0.00 0.00%
S&P 500 2,109.49 9.09 0.43%
market minute promo

Targacept , Inc. (NASDAQ: TRGT)

2.35 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TRGT $2.35 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $2.35
Daily Range $0.00 - $0.00
52-Week Range $2.18 - $4.68
Market Cap $79.5M
P/E Ratio -2.42
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 155,412
Current FY EPS -$1.09

Sector

Healthcare

Industry

Drug Makers

Targacept , Inc. (TRGT) Description

A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system. Website: http://www.targacept.com/

News & Commentary

Keep an Eye on Biogen, Johnson & Johnson, and Merck Today

Biogen, Johnson & Johnson, and Merck could all make health care headlines this morning. Here’s all the news you need to know.

Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog

Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog

Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastropa

Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastroparesis

The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead - Pres

The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead - Press Releases

Biotech Stock Roundup: Alkermes Drug Fares Well, Targacept Slides on Deal Termination - Analyst Blo

Biotech Stock Roundup: Alkermes Drug Fares Well, Targacept Slides on Deal Termination - Analyst Blog

Targacept Crumbles as Pfizer Pulls Out of Collaboration - Analyst Blog

Why I Am Still Long Targacept After The Reverse Merger Announcement

Targacept Management Increases Urgency And Aims For Q4 Strategic Action

Targacept's (TRGT) CEO Dr. Stephen Hill on Q3 2014 Results - Earnings Call Transcript

Targacept (TRGT) Q3 2014 Results - Earnings Call Webcast

See More TRGT News...

TRGT's Top Competitors

TRGT $2.35 (0.00%)
Current stock: TRGT
AMGN $167.92 (1.17%)
Current stock: AMGN
GILD $101.33 (0.67%)
Current stock: GILD
BIIB $424.53 (0.38%)
Current stock: BIIB